4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-023719
Options or other derivatives
- CEO and CFO acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Patel Snehal CEO and CFO | 2025-11-13 | Grant or award · Stock Options | +100,000 | 2,347,462 | D | ||
Loading xslF345X05/ownership.xml…